Your browser doesn't support javascript.
loading
A Phase 1 Clinical Study Evaluating the Effects of Cenobamate on the QT Interval.
Darpo, Borje; Sager, Philip T; Xue, Hongqi; Kamin, Marc.
Affiliation
  • Darpo B; Clario, Philadelphia, Pennsylvania, USA.
  • Sager PT; Cardiovascular Research Institute and Department of Medicine, Stanford University, Palo Alto, California, USA.
  • Xue H; Clario, Philadelphia, Pennsylvania, USA.
  • Kamin M; SK Life Science, Inc., Paramus, New Jersey, USA.
Clin Pharmacol Drug Dev ; 11(4): 523-534, 2022 04.
Article in En | MEDLINE | ID: mdl-35182037
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Long QT Syndrome Type of study: Clinical_trials Limits: Adult / Humans Language: En Journal: Clin Pharmacol Drug Dev Year: 2022 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Long QT Syndrome Type of study: Clinical_trials Limits: Adult / Humans Language: En Journal: Clin Pharmacol Drug Dev Year: 2022 Document type: Article Affiliation country: United States Country of publication: United States